Friday, May 22, 2020

Cannabis is more effective at preventing and treating COVID-19 than hydroxychloroquine


A team of scientists from Canada have identified at least 13 strains of cannabis sativa they believe can aid in the prevention and treatment of COVID-19.

The President of the United States of America has spent the past few weeks touting a dangerous drug called hydroxychloroquine as a prophylactic treatment for COVID-19. Unfortunately, the president’s expertise is in reality TV, not medicine. Several studies have shown that hydroxychloroquine, a drug designed to treat malaria, has dangerous side-effects when used to treat coronavirus, including death.

The quest for a COVID-19 drug that will both make Donald Trump and his friends in the pharmaceutical industry rich and not kill the people who take it has, so far, netted no results. But exciting government-sponsored research out of Canada seems to indicate a different approach is in order.

Per the team’s research paper:

    "We have developed over 800 new Cannabis sativa lines and extracts and hypothesized that high-CBD C. sativa extracts may be used to modulate ACE2 expression in COVID-19 target tissues. Screening C. sativa extracts using artificial human 3D models of oral, airway, and intestinal tissues, we identified 13 high CBD C. sativa extracts that modulate ACE2 gene expression and ACE2 protein levels. Our initial data suggest that some C. sativa extract down-regulate serine protease TMPRSS2, another critical protein required for SARS-CoV2 entry into host cells."

What this means is the team has carefully developed several cannabis strains that have been experimentally shown to make it significantly more difficult for the SARS-CoV2 coronavirus to find a home inside of the tissue cells it latches onto in order to infect us with the COVID-19 disease.  Read more >>